Donald L Hunter CPA

Lindsay & Evans CPAs is a full-service accounting firm located along the Grand Strand, serving Horry and Georgetown Counties in South Carolina. Their comprehensive range of services includes management consulting, tax planning, payroll, bookkeeping, and specialized support for startup companies. The firm boasts a team of highly qualified professionals with expertise in various industries, including healthcare, retail, real estate development, and construction. With two convenient locations in Myrtle Beach and Murrells Inlet, they are dedicated to providing reliable financial solutions tailored to meet the needs of their clients. Generated from the website

Located in the charming coastal city of Myrtle Beach, SC, Lindsay & Evans CPA's is a top-tier accounting firm known for its impeccable reputation and dedication to excellence. With a prime location that caters to both local businesses and individuals, this establishment offers a wide range of financial services tailored to meet the diverse needs of its clients. From tax preparation to financial planning, Lindsay & Evans CPA's prides itself on delivering professional expertise with a personal touch. Their team of seasoned accountants combines industry knowledge with a client-centered approach, ensuring that every financial need is met with precision and care. Whether you're a small business owner or an individual looking for financial guidance, this establishment is a trusted partner in navigating the complex world of accounting. Generated using this place's available information

Novelogics Biotechnology Inc. is a pre-clinical stage biotech company based in Myrtle Beach, SC, that is dedicated to revolutionizing cancer treatment through innovative antibody immunotherapies. With a focus on safety and efficacy, Novelogics aims to address the limitations of current cancer treatments by utilizing their proprietary Interceptor approach, which targets unattached immunosuppressive proteins to enhance the cancer-killing capabilities of the immune system. Led by Co-Founder Dr. Wayne Cheney, a seasoned expert in oncology research and development, Novelogics is actively seeking investments and partnerships to advance their groundbreaking program. With a mission to provide more effective and less harmful treatments for cancer patients, Novelogics Biotechnology Inc. is at the forefront of the rapidly growing field of oncology immunotherapy. By identifying a previously overlooked area in cancer biology, Novelogics has developed a novel antibody immunotherapy that acts as an Interceptor, intercepting immunosuppressive proteins that hinder the immune system's ability to fight cancer. As the sales of oncology immunotherapies continue to rise, Novelogics offers an exciting opportunity for investors and partners to contribute to the advancement of this groundbreaking technology and make a significant impact in the fight against cancer.Generated from the website